Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Page 1
A qualitative study of patient perspectives on colorectal cancer.
Sahay TB, Gray RE, Fitch M. Sahay TB, et al. Among authors: gray re. Cancer Pract. 2000 Jan-Feb;8(1):38-44. doi: 10.1046/j.1523-5394.2000.81012.x. Cancer Pract. 2000. PMID: 10732538
However, some patients were dissatisfied with information concerning long-term management of their illness. Patient care, including information and social support, was provided by cancer specialists, family physicians, family, and friends. ...Information also may need to b …
However, some patients were dissatisfied with information concerning long-term management of their illness. Patient care, including i …
The information needs of well, longer-term survivors of breast cancer.
Gray RE, Fitch M, Greenberg M, Hampson A, Doherty M, Labrecque M. Gray RE, et al. Patient Educ Couns. 1998 Mar;33(3):245-55. doi: 10.1016/s0738-3991(98)00024-x. Patient Educ Couns. 1998. PMID: 9731162
Nine focus groups for well, longer-term survivors of breast cancer were held in Ontario, Canada. Prevalent themes identified through analysis of focus group transcripts fell into two broad categories, one reflecting the context within which women seek information and the o …
Nine focus groups for well, longer-term survivors of breast cancer were held in Ontario, Canada. Prevalent themes identified through …
Aminohexane diphosphonate in the treatment of Paget's disease of bone.
Atkins RM, Yates AJ, Gray RE, Urwin GH, Hamdy NA, Beneton MN, Rosini S, Kanis JA. Atkins RM, et al. Among authors: gray re. J Bone Miner Res. 1987 Aug;2(4):273-9. doi: 10.1002/jbmr.5650020403. J Bone Miner Res. 1987. PMID: 3455614 Free article.
We conclude that short courses of AHDP provide a promising treatment for the long-term control of Paget's disease....
We conclude that short courses of AHDP provide a promising treatment for the long-term control of Paget's disease....
Long-term follow-up observations on treatment in Paget's disease of bone.
Kanis JA, Gray RE. Kanis JA, et al. Among authors: gray re. Clin Orthop Relat Res. 1987 Apr;(217):99-125. Clin Orthop Relat Res. 1987. PMID: 2951050 Review.
Whereas the effects of the calcitonins and mithramycin persist only for the duration of treatment, diphosphonate treatment consistently results in a reduction of disease activity for many months or even years after stopping treatment. The question arises whether the long-term …
Whereas the effects of the calcitonins and mithramycin persist only for the duration of treatment, diphosphonate treatment consistently resu …
Short term high doses of etidronate in Paget's disease of bone.
Kanis JA, Gray RE, Murray SA, Hamdy NA, Urwin GH. Kanis JA, et al. Among authors: gray re. Br Med J (Clin Res Ed). 1986 Jun 21;292(6536):1667. doi: 10.1136/bmj.292.6536.1667. Br Med J (Clin Res Ed). 1986. PMID: 3087565 Free PMC article. Clinical Trial. No abstract available.
Effective short term treatment of Paget's disease with oral etidronate.
Preston CJ, Yates AJ, Beneton MN, Russell RG, Gray RE, Smith R, Kanis JA. Preston CJ, et al. Among authors: gray re. Br Med J (Clin Res Ed). 1986 Jan 11;292(6513):79-80. doi: 10.1136/bmj.292.6513.79. Br Med J (Clin Res Ed). 1986. PMID: 3080099 Free PMC article.
Treatment for one month was associated with transient osteomalacia but sustained suppression of bone resorption. Short term treatments with high doses of disodium etidronate may maximise suppression of disease activity but decrease exposure to unwanted effects....
Treatment for one month was associated with transient osteomalacia but sustained suppression of bone resorption. Short term treatment …
Intravenous clodronate in the treatment and retreatment of Paget's disease of bone.
Yates AJ, Percival RC, Gray RE, Atkins RM, Urwin GH, Hamdy NA, Preston CJ, Beneton MN, Russell RG, Kanis JA. Yates AJ, et al. Among authors: gray re. Lancet. 1985 Jun 29;1(8444):1474-7. doi: 10.1016/s0140-6736(85)92253-6. Lancet. 1985. PMID: 2861411
There was no significant difference in the degree of suppression of alkaline phosphatase activity between patients given intravenous clodronate and 45 patients given clodronate 1.6 g daily by mouth for 6 months. Short-term intravenous clodronate provides a useful alternati …
There was no significant difference in the degree of suppression of alkaline phosphatase activity between patients given intravenous clodron …